Skip to content

Solventum SOLV Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash

Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash at other companies

3M logo
3MMMM
$37M-46.4%
Baxter International logo
Baxter InternationalBAX
-$4M+50.0%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC

Other financials

Income statement

See full
Revenue$2.0B-3.0%
Gross profit$1.1B-1.5%
Operating income$81.0M-46.7%
Net income$13.0M-90.5%
EPS (diluted)$0.07-91.0%

Balance sheet

See full
Cash & equivalents$561.0M+5.1%
Total debt$5.8B-26.8%
Total equity$5.0B+52.3%
Total assets$14.1B-3.0%

Cash flow

See full
Operating cash flow-$189.0M-752%
CapEx$84.0M-22.9%
Free cash flow-$273.0M-241%

Valuation

See full
Market cap$13.06B-13.9%
Enterprise value$18.29B-19.4%
P/E9.1×-30.9×
P/S1.6×-0.2×

Profitability

See full
Gross margin53.7%-0.9pp
Operating margin25.5%+15.8pp
Net margin17.3%+12.8pp
FCF margin4.6%-13.9pp

Returns & leverage

See full
Return on equity34.8%+24.1pp
Debt / equity1.2×-1.3×
Current ratio1.1×-0.1×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash.

The official record: Solventum’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solventum's pension and other postretirement benefits expense (reversal of expense), noncash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solventum's pension and other postretirement benefits expense (reversal of expense), noncash?
Solventum (SOLV) reported pension and other postretirement benefits expense (reversal of expense), noncash of $14M in Q1 2026.
How has Solventum's pension and other postretirement benefits expense (reversal of expense), noncash changed year-over-year?
Solventum's pension and other postretirement benefits expense (reversal of expense), noncash decreased by 6.7% year-over-year, from $15M to $14M.
What is the long-term trend for Solventum's pension and other postretirement benefits expense (reversal of expense), noncash?
Over 3 years (2022 to 2025), Solventum's pension and other postretirement benefits expense (reversal of expense), noncash has grown at a -1.1% compound annual growth rate (CAGR), from $64M to $62M.